NCT06611384 (MIRON-RHYTHM) is a clinical trial in Acute Myocardial Infarction, sponsored by Rohan Dharmakumar.

Who is sponsoring NCT06611384?

NCT06611384 is sponsored by Rohan Dharmakumar.

What condition does NCT06611384 study?

NCT06611384 studies Acute Myocardial Infarction.

Is NCT06611384 still recruiting?

NCT06611384 is currently completed. Last updated 10 March 2026.

Last reviewed 2026-03-10 · How we verify

NCT06611384: MIRON-RHYTHM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Completed Last updated 10 March 2026

What this trial tests

trial in Acute Myocardial Infarction in 250 participants. Completed in 30 March 2025.

Timeline

1 June 2022

Primary endpoint
10 December 2024

30 March 2025

Quick facts

Lead sponsor	Rohan Dharmakumar
Status	Completed
Study type	OBSERVATIONAL
Enrollment	250
Start date	1 June 2022
Primary completion	10 December 2024
Estimated completion	30 March 2025
Sites	2 locations across United States, India

Conditions studied

Acute Myocardial Infarction — all drugs for Acute Myocardial Infarction →

Sponsor

Rohan Dharmakumar — full company profile →

Who can join

Adults 18 to 80, any sex, with Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Myocardial Infarction

Currently open trials in the same condition.

NCT03951467 — Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations · NA · recruiting
NCT07536802 — Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention: A Randomized Control Trial · Phase 4 · recruiting
NCT06947135 — Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury · NA · recruiting
NCT06515730 — Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction · Phase 4 · recruiting
NCT07522164 — Acute Myocardial Infarction Clinical Cohort · active not recruiting

Other Rohan Dharmakumar trials

Trials by the same sponsor.

NCT07502521 — Dexrazoxane to Protect Against Hemorrhagic STEMI · Phase 2 · completed
NCT06162039 — National Landscape of Hemorrhagic Myocardial Infarction in the United States · completed
NCT06423625 — Hemorrhagic MI Prediction Score Model · completed
NCT06851325 — Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes · completed
NCT05604131 — Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06611384 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rohan Dharmakumar
Last refreshed: 10 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06611384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing